Strait of Hormuz blockage upends global helium supply. This U.S. company could benefit

UBS reiterated a $171 12-month price target on Exxon Mobil, implying roughly 5% upside from Monday's $163.37 close. LaBarge supplies ~20% of global helium with ~1.4 billion cubic feet/year capacity; spot helium has surged to $1,000–$1,200 per 1,000 cf (vs ~ $500 on older contracts), and UBS estimates Exxon would earn ~$119M EBITDA for every $100 rise in spot prices at 85% utilization ($140M at 100%). Exxon has risen ~36% YTD (ex-dividend) and yields 2.56%, positioning it as a clear beneficiary of Middle East-driven helium supply disruptions.

Analysis

The market is treating helium dislocation as a tailwind to a major E&P integrated name, but the real lever is optionality in monetization and capital allocation rather than a one-off commodity windfall. If management prioritizes returning incremental cash via buybacks/dividend increases, equity EPS can ratchet higher quickly with only modest, sustained price dislocations; if they redeploy into upstream or industrial partnerships the benefit compounds more slowly but widens moat versus industrial-gas peers.

Second-order winners include companies owning stable domestic separation infrastructure, logistics (cryogenic transport) and specialty gas trading desks that can flex volumes quickly; losers are large industrial-gas firms with concentrated foreign feedstock exposed to single-region outages and semiconductor fabs with low inventory. Expect semiconductor OEMs to accelerate on-site recycling and longer-term procurement contracts, which will blunt spot price pass-through after 6–18 months and cap upside for producers selling on the spot market.

Key risk timers: diplomatic de-escalation or restart of external feedstock flows can normalize prices within weeks–months; conversely, supply-chain frictions (shipping, insurance or regulatory export controls) can extend tightness into multiple years. Operational risk at domestic facilities (permit delays, fractionation bottlenecks) and contract mix (long-term fixed-price vs spot) are high-conviction throttles to realized EBITDA — don’t conflate headline tightness with immediate free-cash-flow realization without parsing contract exposure and utilization assumptions.

Key Decisions for Investors

• Buy XOM shares (6–12 month horizon). Target +17% upside to $190, stop-loss at -12% (~$144). Rationale: asymmetric return if management levers buybacks/dividend from incremental helium cashflows; hedge macro risk with 3–6 month 10% OTM puts costing no more than 2–3% of position size.
• Call-spread for leveraged upside: Buy XOM Jan-2027 175/250 call spread (debit structure). Max loss = premium; breakeven requires sustained commodity-driven rerating and capital-return tailwinds. Timeframe: 12+ months to allow re-rating and capital allocation changes; expected reward 2–4x if thesis plays out.
• Relative-value pair (3–6 months): Long XOM / Short LIN or APD (size 1:0.6). Rationale: capture security-of-supply premium versus industrial-gas majors more exposed to foreign feedstock; set pair stop when spread narrows >8% intraday or after a positive supply-restoration announcement.
• Protective hedge (event insurance, near-term): Purchase 3-month XOM puts 8–12% OTM sized to cover 25–30% of equity exposure while holding longs. Cost is the insurance premium; protects against rapid geopolitical escalation that hits oil/operational logistics and compresses the trade’s realized upside.